Abstract
In response to the recent article by Rubio-Muñiz et al., and in agreement with the title of their interesting work, we consider that topical cidofovir is a valuable option for skin lesions caused by monkeypox based on a recent publication of ours.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have